Clinical trials
Terminated Phase 2 Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Dana-Farber Cancer Institute | 2 |
| Fred Hutchinson Cancer Center | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| AHS Cancer Control Alberta | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| CABYC | 1 |
| CytoDyn, Inc. | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 32 |
| Myelodysplastic Syndromes | 10 |
| Leukemia | 8 |
| Leukemia, Myeloid, Acute | 6 |
| Lymphoma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Leukemia, Myeloid, Accelerated Phase | 5 |
| Multiple Myeloma | 5 |
| Primary Myelofibrosis | 5 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.